The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Murkamilov I.T.

Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan;
Kyrgyz Russian Slavic University named after the First President of Russia B.N. Yeltsin, Bishkek, Kyrgyzstan

Lunegova O.S.

National Centre of Cardiology and Therapy, Bishkek, Kyrgyz Republic

Kaliev R.R.

Kafedra terapii obshcheĭ praktiki s kursom semeĭnoĭ meditsiny Kyrgyzskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. I.K. Akhunbaeva

Authors:

Murkamilov I.T., Lunegova O.S., Kaliev R.R.

More about the authors

Journal: Therapeutic Archive. 2013;85(12): 71‑74

Read: 861 times

To cite this article:

Murkamilov IT, Lunegova OS, Kaliev RR. . Therapeutic Archive. 2013;85(12):71‑74. (In Russ.)

References:

  1. Tareeva I.E. Nefrologiya: rukovodstvo dlya vrachei. M: Meditsina 2000; 688.
  2. Al-Khoury S., Afzali B., Shah N. et al. Anaemia in diabetic patients with chronic kidney disease- prevalence and predictors. Diabetologia 2006; 49 (6): 1183-1189.
  3. Milovanov Yu.S., Kozlovskaya L.V., Milovanova L.Yu. Lechenie anemii u bol'nykh khronicheskoi pochechnoi nedostatochnost'yu na dodializnom etape. Lech vrach 2006; 7: 12-23.
  4. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Inter 2012; 2: 114-164.
  5. Eschbach J.W. Te anemia of chronic renal failure: pathophysiology and the efects of recombinant erythropoietin. Kidney Int 1989; 35: 134-148.
  6. Kalyagin A.N. Anemiya kak faktor riska neblagopriyatnogo prognoza khronicheskoi serdechnoi nedostatochnosti. Tez. II kongr. Obshchestva spetsialistov po serdechnoi nedostatochnosti "Serdechnaya nedostatochnost''2007", Moskva 5-7 dekabrya 2007 goda. M 2007: 17.
  7. Shlyakhto E.V., Konradi A.O. Remodelirovanie serdtsa pri gipertonicheskoi bolezni. Serdtse 2002; 5: 13-18.
  8. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 (Suppl 3): SM2-S119.
  9. Sarnak M.J, Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35 (Suppl 1): S117-S131.
  10. Locatelli F., Aljama P., Barany P. et al. Revised European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol. Dial. Transplant 2004; 19 (Suppl 2): ii1-ii47.
  11. Novikov V.I. Metodika ekhokardiografii. SPb 1994; 9-47.
  12. Devereux R.B. Metods of recognition and assessment of left ventricular hypertrophy. Mediographia 1995; 17 (1): 12-16.
  13. Weiss L.G., Clyne N., Fihlho J.D. et al. The efficacy of one weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicenter trial. Nephrol Dial Transplant 2000; 15: 2014-2019.
  14. Krikorian S.A. Managing anemia of chronic kidney disease. Am J Lifestyle Med 2009; 3 (2): 136-146.
  15. Mukhin N.A. Snizhenie skorosti klubochkovoi obshchepopulyatsionnyi marker neblagopriyatnogo prognoza. Ter arkh 2007; 6: 5-10.
  16. McCleellan W., Aronof S.L., Bolton W.K. et al. The prevalence of anemia in patients with chronis kidney disease. Curr Med Res Opin 2004; 9: 1501-1510.
  17. Actor B.C., Coresh J., Heiss G. et al. Kidney function and anemia as risk factor for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIS) Study. Am Heart J 2006; 151 (2): 492-500.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.